Cancer-related neuropathic pain in out-patient oncology clinics: a European survey

Table 5 Summary of characteristics and type of cancer ^a in patients with CRNP

Characteristic	n = 310
Cancer type, n (%)
Breast	56 (18.06)
Lung	45 (14.52)
Prostate	27 (8.71)
Colorectal	37 (11.94)
Other^b	95 (30.65)
Missing data	55 (17.74)
Loco-regional progression of the cancer, n (%)
Yes	137 (44.19)
No	104 (33.55)
Missing data	69 (22.26)
Sites of metastasis^c, n (%)
Brain	9 (2.90)
Bone	113 (36.45)
Lung	60 (19.35)
Lymph node	77 (24.84)
Liver	40 (12.90)
Other	42 (13.55)
Missing data	117 (37.74)
Total number of sites of metastasis, n (%)
0	35 (11.29)
1	62 (20.00)
2	53 (17.10)
3	24 (7.74)
4	8 (2.58)
5	2 (0.65)
7	1 (0.32)
10	2 (0.65)
Missing data	123 (39.68)

^aA single patient could have more than one primary diagnoses.
^bOther cancer types included: sarcoma, myeloma, cervical, pancreatic, renal, bladder, endometrial and head and neck cancer as well as other MedDRA lowest level term types of cancer, including unknown primary cancer.
^cFor site of metastasis more than one response was possible.
CRNP, cancer-related neuropathic pain; MedDRA, Medical Dictionary for Regulatory Activities.

ISSN: 1472-684X